T. Rowe Price Associates’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Buy |
279,237
+18,396
| +7% | +$22.9K | ﹤0.01% | 2464 |
|
|
2025
Q1 | $308K | Sell |
260,841
-1,510,812
| -85% | -$1.78M | ﹤0.01% | 2461 |
|
|
2024
Q4 | $3.24M | Sell |
1,771,653
-67,099
| -4% | -$123K | ﹤0.01% | 1419 |
|
|
2024
Q3 | $3.13M | Sell |
1,838,752
-100,482
| -5% | -$171K | ﹤0.01% | 1440 |
|
|
2024
Q2 | $2.66M | Sell |
1,939,234
-16,148
| -0.8% | -$22.1K | ﹤0.01% | 1436 |
|
|
2024
Q1 | $7.33M | Sell |
1,955,382
-1,643,893
| -46% | -$6.17M | ﹤0.01% | 1155 |
|
|
2023
Q4 | $35.3M | Sell |
3,599,275
-389,435
| -10% | -$3.82M | ﹤0.01% | 794 |
|
|
2023
Q3 | $33.3M | Buy |
3,988,710
+98,788
| +3% | +$825K | ﹤0.01% | 785 |
|
|
2023
Q2 | $51.7M | Buy |
3,889,922
+248,110
| +7% | +$3.3M | 0.01% | 695 |
|
|
2023
Q1 | $42.2M | Buy |
3,641,812
+216,045
| +6% | +$2.5M | 0.01% | 725 |
|
|
2022
Q4 | $28M | Buy |
3,425,767
+55,139
| +2% | +$451K | ﹤0.01% | 827 |
|
|
2022
Q3 | $19.6M | Sell |
3,370,628
-6,913,462
| -67% | -$40.2M | ﹤0.01% | 910 |
|
|
2022
Q2 | $45.5M | Buy |
10,284,090
+4,179,997
| +68% | +$18.5M | 0.01% | 904 |
|
|
2022
Q1 | $55.5M | Buy |
6,104,093
+270,289
| +5% | +$2.46M | 0.01% | 936 |
|
|
2021
Q4 | $118M | Buy |
5,833,804
+84,468
| +1% | +$1.71M | 0.01% | 713 |
|
|
2021
Q3 | $145M | Buy |
5,749,336
+2,214,524
| +63% | +$56M | 0.01% | 647 |
|
|
2021
Q2 | $124M | Sell |
3,534,812
-5,487
| -0.2% | -$192K | 0.01% | 710 |
|
|
2021
Q1 | $118M | Buy |
3,540,299
+221,559
| +7% | +$7.38M | 0.01% | 719 |
|
|
2020
Q4 | $86.1M | Buy |
3,318,740
+942,147
| +40% | +$24.4M | 0.01% | 780 |
|
|
2020
Q3 | $23.5M | Buy |
2,376,593
+2,291,714
| +2,700% | +$22.6M | ﹤0.01% | 1112 |
|
|
2020
Q2 | $293K | Sell |
84,879
-51,340
| -38% | -$177K | ﹤0.01% | 2252 |
|
|
2020
Q1 | $417K | Buy |
136,219
+41,441
| +44% | +$127K | ﹤0.01% | 2063 |
|
|
2019
Q4 | $487K | Buy |
94,778
+5,541
| +6% | +$28.5K | ﹤0.01% | 2152 |
|
|
2019
Q3 | $460K | Buy |
89,237
+750
| +0.8% | +$3.87K | ﹤0.01% | 2129 |
|
|
2019
Q2 | $535K | Buy |
88,487
+47,338
| +115% | +$286K | ﹤0.01% | 2082 |
|
|
2019
Q1 | $298K | Buy |
41,149
+400
| +1% | +$2.9K | ﹤0.01% | 2289 |
|
|
2018
Q4 | $302K | Buy |
40,749
+423
| +1% | +$3.14K | ﹤0.01% | 2269 |
|
|
2018
Q3 | $218K | Sell |
40,326
-752
| -2% | -$4.07K | ﹤0.01% | 2431 |
|
|
2018
Q2 | $146K | Buy |
41,078
+252
| +0.6% | +$896 | ﹤0.01% | 2487 |
|
|
2018
Q1 | $84K | Buy |
40,826
+202
| +0.5% | +$416 | ﹤0.01% | 2497 |
|
|
2017
Q4 | $107K | Sell |
40,624
-29,900
| -42% | -$78.8K | ﹤0.01% | 2483 |
|
|
2017
Q3 | $370K | Hold |
70,524
| – | – | ﹤0.01% | 2183 |
|
|
2017
Q2 | $251K | Buy |
70,524
+24
| +0% | +$85 | ﹤0.01% | 2299 |
|
|
2017
Q1 | $364K | Hold |
70,500
| – | – | ﹤0.01% | 2179 |
|
|
2016
Q4 | $268K | Hold |
70,500
| – | – | ﹤0.01% | 2288 |
|
|
2016
Q3 | $632K | Buy |
70,500
+54,600
| +343% | +$489K | ﹤0.01% | 1916 |
|
|
2016
Q2 | $112K | Sell |
15,900
-15,000
| -49% | -$106K | ﹤0.01% | 2409 |
|
|
2016
Q1 | $263K | Hold |
30,900
| – | – | ﹤0.01% | 2207 |
|
|
2015
Q4 | $406K | Sell |
30,900
-22,900
| -43% | -$301K | ﹤0.01% | 2040 |
|
|
2015
Q3 | $197K | Buy |
53,800
+30,200
| +128% | +$111K | ﹤0.01% | 2292 |
|
|
2015
Q2 | $136K | Hold |
23,600
| – | – | ﹤0.01% | 2418 |
|
|
2015
Q1 | $138K | Hold |
23,600
| – | – | ﹤0.01% | 2423 |
|
|
2014
Q4 | $185K | Sell |
23,600
-15,200
| -39% | -$119K | ﹤0.01% | 2373 |
|
|
2014
Q3 | $191K | Hold |
38,800
| – | – | ﹤0.01% | 2357 |
|
|
2014
Q2 | $240K | Hold |
38,800
| – | – | ﹤0.01% | 2283 |
|
|
2014
Q1 | $208K | Buy |
38,800
+9,500
| +32% | +$50.9K | ﹤0.01% | 2305 |
|
|
2013
Q4 | $153K | Sell |
29,300
-33,800
| -54% | -$176K | ﹤0.01% | 2362 |
|
|
2013
Q3 | $349K | Sell |
63,100
-20,000
| -24% | -$111K | ﹤0.01% | 2046 |
|
|
2013
Q2 | $209K | Buy |
+83,100
| New | +$209K | ﹤0.01% | 2197 |
|